Table 1 Baseline demographic and clinical characteristics
Characteristics | NTZ-JCV positive (n = 83) | NTZ-JCV negative (n = 101) | P-value |
|---|---|---|---|
Age at disease onset (years), mean (SD) | 29 (10) | 26.5 (8.4) | 0.07 |
Age at stratify (years), mean (SD) | 39.6 (10.4) | 38 (10.5) | 0.29 |
Female (%) | 53 (63.9) | 74 (73.3) | 0.20 |
Disease duration (years), mean (SD) | 11.3 (8.1) | 11.4 (8.6) | 0.94 |
EDSS pre-stratify, median [IQR]; mean (SD) | 3.5 (2–5); 3.1 (1.9) | 3 (2–4); 3 (1.6) | 0.017 |
Relapses year before stratify, median [IQR]; mean (SD) | 1 (1–2); 1.34 (0.86) | 1nn; 1.39 (0.80) | 0.62 |
T2 lesions pre–stratify, mean (SD; IQR) | 51.2 (38.5; 21–65) | 51.6 (37.4; 20–70) | 0.82 |